Myelin News and Research

RSS

Myelin is the fatty substance that covers and protects nerves.

Nicotinamide may help people with multiple sclerosis

Researchers have found a possible way to protect people with multiple sclerosis (MS) from severe long-term disability: increase nervous-system levels of a vital compound, called nicotinamide adenine dinucleotide (NAD), by giving its chemical precursor - nicotinamide, a form of vitamin B3.

19 Sep 2006

Whole-brain T1 mapping in multiple sclerosis

The effects of multiple sclerosis (MS) extend beyond visibly affected areas into large portions of the brain that outwardly appear normal, according to a study appearing in the September issue of Radiology.

30 Aug 2006

Researchers discover a cellular signal that aggravates the symptoms of multiple sclerosis

Depression, coordination and speech problems, muscle weakness and disability are just a few of the symptoms of Multiple Sclerosis (MS).

6 Aug 2006

Study establishes safety of spinal cord stem cell transplantation

Transplanting human embryonic stem cells does not cause harm and can be used as a therapeutic strategy for the treatment of acute spinal cord injury, according to a recent study by UC Irvine researchers.

19 Jul 2006

First trial to investigate effects of cannabinoids on progression of multiple sclerosis

Clinicians from across the UK have now embarked on the world's first trial to investigate whether cannabis derivatives could play a role in slowing the progression of multiple sclerosis.

11 Jul 2006

Scientists use embryonic stem cells to awaken latent motor nerve repair

In a dramatic display of stem cells' potential for healing, a team of Johns Hopkins scientists reports that they've engineered new, completed, fully-working motor neuron circuits - neurons stretching from spinal cord to target muscles - in paralyzed adult animals.

26 Jun 2006

Stem cell breakthrough

Researchers at The Hospital for Sick Children (SickKids) and the University of Calgary have found that stem cells derived from adult skin can create neural cell types that can be transplanted into and function in mouse models of disease.

14 Jun 2006

Pros and cons of starting multiple sclerosis treatment early

An editorial accompanying a published debate on the pros and cons of starting treatment early in the course of multiple sclerosis comes down in favor of early treatment for this potentially devastating disease.

23 May 2006

Interferon-gamma plays a critical role in damaging the cells that produce myelin

A new way to preserve the cells that surround and protect nerves could lead to new treatments for demyelinating diseases such a multiple sclerosis, a research team reports in the May 10, 2006, issue of the Journal of Neuroscience.

10 May 2006

New approaches to genetic disease, based on cells' own ability to correct themselves

New approaches to genetic disease, based on cells' own ability to correct themselves, will be outlined today at the annual conference of the European Society of Human Genetics in Amsterdam, The Netherlands.

8 May 2006

Epstein-Barr virus may trigger multiple sclerosis

Researchers have found that patients with multiple sclerosis (MS) carry a population of immune cells that overreact to Epstein-Barr virus.

3 May 2006

New insights into how anti-rejection drug daclizumab (Zenapax) helps MS patients

A research team led by the University of Cincinnati's Bibiana Bielekova, MD, report new insights into the role of the MS drug daclizumab (Zenapax) in the Proceedings of the National Academy of Sciences.

11 Apr 2006

Stem cells can repair damaged spinal tissue and help restore function in rats with spinal cord injuries

Each year, some 11,000 Americans sustain spinal cord injury, most often in traffic accidents. Costs of the condition approach $10 billion per year.

11 Apr 2006

Cell therapy slows progression of metachromatic leukodystrophy

In an important discovery, scientists have demonstrated that the progression of a type of genetic brain disease is slowed and symptoms are improved in mice that received cell transplants.

23 Mar 2006

Atorvastatin could prove an effective therapy for multiple sclerosis

Scientists at the University of California, San Francisco and Stanford University Medical Center are reporting compelling new evidence that the cholesterol-lowering drug atorvastatin could prove an effective therapy for preventing the progression of, and reversing the severity of, multiple sclerosis (MS).

20 Mar 2006

Penn researchers study link between potassium and sodium channels aiming at new treatments for neurological diseases

Researchers at the University of Pennsylvania School of Medicine have discovered the mechanism that facilitates how two ion channels collaborate in the control of electrical signals in the brain.

9 Mar 2006

Will the FDA rise to the occasion and admit their natalizumab mistake?

When Anita Louise Smith enrolled in an experimental drug trial in 2002 in Colorado, she had a diagnosis of multiple sclerosis but no symptoms and was looking to reduce the chances of being ravaged by the disease.

7 Mar 2006

Johns Hopkins scientists identify protein fragment which may lead to a simple test for multiple sclerosis

Johns Hopkins scientists report the discovery of a protein found only in cerebrospinal fluid that they say might be useful in identifying a subgroup of patients with multiple sclerosis (MS) or identifying those at risk for the debilitating autoimmune disorder.

7 Mar 2006

Reparative cells offers new avenue for fighting multiple sclerosis

Plaques that form around the nerve cells of people with multiple sclerosis are apparently what disable people with the disease. But partly developed reparative cells within the plaques provide hope for a treatment, a UT Southwestern physician reports in the New England Journal of Medicine.

7 Mar 2006

Study may provide new hope for cancer patients

New study by Mount Sinai researchers may lead to improved stem cell therapies for patients with compromised immune systems due to intensive cancer therapy or autoimmune disease. The study is published in this week's issue of Cell.

27 Jan 2006

Myelin News and Research

Further Reading

Nicotinamide may help people with multiple sclerosis

Whole-brain T1 mapping in multiple sclerosis

Researchers discover a cellular signal that aggravates the symptoms of multiple sclerosis

Study establishes safety of spinal cord stem cell transplantation

First trial to investigate effects of cannabinoids on progression of multiple sclerosis

Scientists use embryonic stem cells to awaken latent motor nerve repair

Stem cell breakthrough

Pros and cons of starting multiple sclerosis treatment early

Interferon-gamma plays a critical role in damaging the cells that produce myelin

New approaches to genetic disease, based on cells' own ability to correct themselves

Epstein-Barr virus may trigger multiple sclerosis

New insights into how anti-rejection drug daclizumab (Zenapax) helps MS patients

Stem cells can repair damaged spinal tissue and help restore function in rats with spinal cord injuries

Cell therapy slows progression of metachromatic leukodystrophy

Atorvastatin could prove an effective therapy for multiple sclerosis

Penn researchers study link between potassium and sodium channels aiming at new treatments for neurological diseases

Will the FDA rise to the occasion and admit their natalizumab mistake?

Johns Hopkins scientists identify protein fragment which may lead to a simple test for multiple sclerosis

Reparative cells offers new avenue for fighting multiple sclerosis

Study may provide new hope for cancer patients

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News